Sort
85,873 grants matching “alzheimers”
Progress Report for Neurotherapeutics Unit
$1,793,171Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Massachusetts Alzheimer's Disease Research Center
$1,792,939Bradley T Hyman · Massachusetts General Hospital · P50 · FY2006 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,792,741Charbel Moussa · Georgetown University · R01 · FY2021 · AG
Novel Implantable Smart Magnetoelectric NanoRFIDs for Large-Scale Neural Magnetic Recording and Modulation
$1,792,714Nian Xiang Sun · Northeastern University · UF1 · FY2018 · NS
AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR
$1,792,500University Of Southern California · P01 · FY2001 · AG
Frontotemporal Dementia: Genes, Images, and Emotions (supplement)
$1,791,998Bruce L Miller · University Of California, San Francisco · P01 · FY2022 · AG
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,791,614Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2024 · AG
University of Kansas Alzheimer's Disease Core Centers
$1,791,559Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2019 · AG
Metabolic Control Analysis
$1,790,340Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA
Risk Factors for Incident Alzheimer's Disease
$1,789,817Rush University Medical Center · R01 · FY2004 · AG
Effects of Care Setting on Persons with Alzheimer's Disease and their Spouses
$1,789,478Rita Tamara Konetzka · University Of Chicago · RF1 · FY2017 · AG
Molecular Pathogenesis of Age-Dependent CNS Degeneration
$1,789,472Stanley B Prusiner · University Of California, San Francisco · P01 · FY2008 · AG
Migration and outcomes among older adults with and without ADRD from Puerto Rico
$1,788,638Maricruz Rivera-Hernandez · Brown University · RF1 · FY2023 · AG
Neuropathology in tauopathies stem from depolarization-induced alterations in the planar distribution of phosphoinositides
$1,788,346Kartik Venkatachalam · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2020 · AG
Gene therapy for Alzheimer's disease using virally delivered Aβ variants
$1,788,342Joanna L Jankowsky · Baylor College Of Medicine · RF1 · FY2021 · AG
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
$1,788,201Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network
$1,787,678Michelle M Mielke · Wake Forest University Health Sciences · U24 · FY2025 · AG
MICHIGAN ALZHEIMERS DISEASE RESEARCH CENTER
$1,787,637University Of Michigan At Ann Arbor · P50 · FY2003 · AG
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$1,786,110Jessica Alber · University Of Rhode Island · R01 · FY2024 · AG
STRESS, AGING AND WOUND HEALING
$1,786,053Ohio State University · P01 · FY2001 · AG
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids
$1,785,477Zhexing Wen · Emory University · RF1 · FY2025 · AG
Deubiquitinase USP19 in TDP-43 pathogenesis.
$1,785,220David E Kang · Case Western Reserve University · RF1 · FY2022 · NS
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
$1,784,788Ed Lein · Allen Institute · U19 · FY2022 · AG
ARIC Neurocognitive Study
$1,784,185Thomas H Mosley · University Of Mississippi Med Ctr · U01 · FY2010 · HL
Omega-3, isoflavones & amyloid deposition in cognitively normal elderly Japanese
$1,783,798Akira Sekikawa · University Of Pittsburgh At Pittsburgh · RF1 · FY2016 · AG